A Retrospective Review of Malignant Liver Tumors

Completed

Conditions studied: Liver Cancer

In brief

This study will review the treatment and outcomes of patients having primary and metastatic hepatic malignancies. Patients treated with surgical resection, percutaneous radiofrequency ablation (RFA), and transarterial chemoembolization (TACE) will be compared with patients not receiving these treatments. Tumor recurrence and survival data will be compared to the published literature to determine the efficacy of current treatment strategies in this patient population.

Key facts

Study ID

NCT00728650

Run by

University of Oklahoma

People needed

228

Starts

2003-10-01

Expected to finish

2011-06-01

Last updated by the study team

2012-02-07

Who can join

Age: 20 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with primary or metastatic hepatic malignancies

You may not qualify if…

• Patients not diagnosed with primary or metastatic hepatic malignancies

Where it is running

• The University of Oklahoma College of Medicine, Tulsa - Department of Surgery — Tulsa, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.